Mitsubishi UFJ Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-32,961
| Closed | -$1.37M | – | 1549 |
|
|
2023
Q2 | $1.37M | Buy |
32,961
+131
| +0.4% | +$5.44K | ﹤0.01% | 790 |
|
|
2023
Q1 | $1.97M | Buy |
32,830
+4,850
| +17% | +$292K | ﹤0.01% | 734 |
|
|
2022
Q4 | $1.9M | Buy |
27,980
+43
| +0.2% | +$2.92K | 0.01% | 726 |
|
|
2022
Q3 | $2.12M | Buy |
27,937
+4,803
| +21% | +$365K | 0.01% | 693 |
|
|
2022
Q2 | $1.61M | Hold |
23,134
| – | – | 0.01% | 744 |
|
|
2022
Q1 | $1.92M | Sell |
23,134
-510
| -2% | -$42.3K | 0.01% | 745 |
|
|
2021
Q4 | $1.89M | Buy |
23,644
+1,376
| +6% | +$110K | 0.01% | 766 |
|
|
2021
Q3 | $2.59M | Buy |
22,268
+2,280
| +11% | +$265K | 0.01% | 697 |
|
|
2021
Q2 | $4.43M | Buy |
19,988
+1,395
| +8% | +$309K | 0.02% | 589 |
|
|
2021
Q1 | $2.46M | Buy |
18,593
+2,447
| +15% | +$323K | 0.02% | 656 |
|
|
2020
Q4 | $2.79M | Sell |
16,146
-7,154
| -31% | -$1.24M | 0.02% | 580 |
|
|
2020
Q3 | $2.59M | Sell |
23,300
-15,300
| -40% | -$1.7M | 0.02% | 526 |
|
|
2020
Q2 | $2.29M | Buy |
38,600
+6,500
| +20% | +$385K | 0.03% | 503 |
|
|
2020
Q1 | $2.16M | Buy |
32,100
+12,900
| +67% | +$869K | 0.03% | 437 |
|
|
2019
Q4 | $1.44M | Buy |
19,200
+12,800
| +200% | +$959K | 0.02% | 625 |
|
|
2019
Q3 | $479K | Buy |
+6,400
| New | +$479K | 0.01% | 745 |
|
|
2018
Q4 | – | Sell |
-2,929
| Closed | -$153K | – | 933 |
|
|
2018
Q3 | $153K | Sell |
2,929
-307
| -9% | -$16K | ﹤0.01% | 801 |
|
|
2018
Q2 | $101K | Sell |
3,236
-299
| -8% | -$9.33K | ﹤0.01% | 798 |
|
|
2018
Q1 | $77K | Buy |
+3,535
| New | +$77K | ﹤0.01% | 808 |
|